Product Images Kesimpta
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 26 images provide visual information about the product associated with Kesimpta NDC 0078-1007 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1: Time to First 3-month Confirmed Disability Progression by Treatment Full Analysis Set - omb157g 01
This appears to be a comparison of the risks and event rates for two drugs, KESIMPTA and Teriflunomide, with 544 and 932 individuals respectively. The Kaplan-Meier estimate of cumulative event rate is shown across 33 months, and the risk reduction percentage for KESIMPTA is reported to be 4%.*
PRINCIPAL DISPLAY PANEL NDC 0078-1007-68 Rx only Kesimpta® (ofatumumab) Injection 20 mg/0.4 mL Single-dose Prefilled Sensoready® Pen For Subcutaneous Use Only Sterile Solution - Contains No Preservatives Carton contains: 1 Single-dose Prefilled Sensoready ® Pen, Prescribing Information, Instructions for Use, and Medication Guide Attention: Dispense with enclosed Medication Guide. REFRIGERATE NOVARTIS - omb157g 02
Kesimpta is a prescription drug that comes in a single-dose prefilled Sensoready Pen. It contains 20mg of ofatumumab, and other inactive ingredients including arginine, sodium edetate, polysorbate 80, sodium acetate, sodium chloride, and Water for injection. It is stored refrigerated at 2°C to 8°C until the time of use to protect it from light. Prior to injection, it should be inspected for visible particles or cloudiness. It should not be shaken or frozen. The drug should be discarded after use. The pH is adjusted using hydrochloric acid. It is intended for subcutaneous use only, and should be kept out of reach of children. For more details, refer to the prescribing information and medication guide. For queries, visit www.ksimpta.com or call 1-838-NOW-NOVA (1-838-669-6682).*
Figure J - omb157g 03
Figure A - omb157g 04
The text describes various components of a needle, including a needle guard, a cap with a viewing window, and an internal needle cover. It is likely referring to a medical device such as a syringe or an injection pen.*
Figure B - omb157g 05
Figure C - omb157g 06
Figure D - omb157g 07
This text is a short phrase indicating the presence of a "viewing window". It doesn't provide further context or details, but suggests that there may be a feature or device with a window through which something can be seen.*
Figure E - omb157g 08
Figure F - omb157g 09
Figure G - omb157g 10
Figure H - omb157g 11
Figure I - omb157g 12
Correct/Incorrect image - omb157g 13
Figure I - omb157g 14
Figure J - omb157g 15
Figure K - omb157g 16
Figure L - omb157g 17
Figure M - omb157g 18
Figure A - omb157g 19
This appears to be a description of a syringe with features such as finger grips, needle cap, plunger head and syringe guard body with wings. It also mentions a viewing window for the medication and a label with an expiration date.*
Figure B - omb157g 20
Figure C - omb157g 21
Figure D - omb157g 22
Figure E - omb157g 23
Figure F - omb157g 24
Figure G - omb157g 25
Figure H - omb157g 26
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.